Loading market dashboard
TNF Pharmaceuticals, Inc.
TNFAHealthcareNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
TNF Pharmaceuticals, Inc. (NASDAQ: TNFA - Get Free Report) shares shot up 0.8% during trading on Thursday. The stock traded as high as $4.15 and last traded at $3.83. 459,933 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 32,220,806 shares. The stock had previously closed at $3.80.
TNF Pharmaceuticals (NASDAQ: TNFA - Get Free Report) and Altimmune (NASDAQ: ALT - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability. Risk and Volatility TNF Pharmaceuticals has a beta
